RE-BVS – Piemonte Repository

Sfoglia per AUTORE
GORZEGNO G
Collezione AOU San Luigi di Orbassano

Items : 23

Systemic recurrence of endometrial cancer more than 10?years after hysterectomy: a report of two cases and a brief review of the literature. in Journal of the Egyptian National Cancer Institute / J Egypt Natl Canc Inst. 2020 Nov 2;32(1):41. doi: 10.1186/s43046-020-00052-2.

2020
AOU San Luigi di Orbassano

Muratori L; Sperone P; Gorzegno G; La Salvia A; Scagliotti GV;

Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment. in Gynecologic oncology reports / Gynecol Oncol Rep. 2019 Feb 16;28:44-46. doi: 10.1016/j.gore.2019.02.004. eCollection 2019 May.

2019
AOU San Luigi di Orbassano

Muratori L; Gorzegno G; Sperone P; Andreozzi A; Di Maio M; Scagliotti GV;

Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy. in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation / Qual Life Res. 2010 May;19(4):531-7. doi: 10.1007/s11136-010-9614-8. Epub 2010 Feb 27.

2010
AOU San Luigi di Orbassano

Ostacoli L; Saini A; Ferini-Strambi L; Castronovo V; Sguazzotti E; Picci RL; Toje M; Gorzegno G; Capogna S; Dongiovanni V; Dogliotti L; Furlan PM; Berruti A;

Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2009;12(1):94-9. doi: 10.1038/pcan.2008.10. Epub 2008 Mar 11.

2009
AOU San Luigi di Orbassano

Tucci M; Mosca A; Lamanna G; Porpiglia F; Terzolo M; Vana F; Cracco C; Russo L; Gorzegno G; Tampellini M; Torta M; Reimondo G; Poggio M; Scarpa RM; Angeli A; Dogliotti L; Berruti A;

Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients. in Anticancer research / Anticancer Res. 2008 Sep-Oct;28(5B):3055-60.

2008
AOU San Luigi di Orbassano

Bitossi R; Sculli CM; Tampellini M; Alabiso I; Brizzi MP; Ferrero A; Ottone A; Bellini E; Gorzegno G; Berruti A; Dogliotti L;

Development and validation of a patient-physician relationship index in the advanced cancer setting. in Tumori / Tumori. 2007 Sep-Oct;93(5):485-90. doi: 10.1177/030089160709300513.

2007
AOU San Luigi di Orbassano

Ostacoli L; Costantini M; Beccaro M; Dellai M; Gorzegno G; Picci RL; Sguazzotti E; Berruti A; Torta R; Furlan PM;

Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane. in Journal of endocrinological investigation / J Endocrinol Invest. 2006 Jun;29(6):560-2. doi: 10.1007/BF03344148.

2006
AOU San Luigi di Orbassano

Sperone P; Berruti A; Gorzegno G; Paccotti P; Terzolo M; Porpiglia F; Angeli A; Dogliotti L;

The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients. in British journal of cancer / Br J Cancer. 2006 Jul 3;95(1):13-20. doi: 10.1038/sj.bjc.6603204. Epub 2006 Jun 13.

2006
AOU San Luigi di Orbassano

Tampellini M; Saini A; Alabiso I; Bitossi R; Brizzi MP; Sculli CM; Berruti A; Gorzegno G; Magnino A; Sperti E; Miraglia S; Forti L; Alabiso O; Aglietta M; Harris A; Dogliotti L;

Recall inflammatory skin reaction after use of pegylated liposomal doxorubicin in site of previous drug extravasation. in The Lancet. Oncology / Lancet Oncol. 2006 Feb;7(2):186-7. doi: 10.1016/S1470-2045(06)70582-4.

2006
AOU San Luigi di Orbassano

Saini A; Berruti A; Sperone P; Bitossi R; Tampellini M; Dogliotti L; Gorzegno G;

Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients. in Breast cancer research and treatment / Breast Cancer Res Treat. 2006 Aug;98(3):241-8. doi: 10.1007/s10549-005-9155-y. Epub 2006 May 3.

2006
AOU San Luigi di Orbassano

Tampellini M; Berruti A; Bitossi R; Gorzegno G; Alabiso I; Bottini A; Farris A; Donadio M; Sarobba MG; Manzin E; Durando A; Defabiani E; De Matteis A; Ardine M; Castiglione F; Danese S; Bertone E; Alabiso O; Massobrio M; Dogliotti L;

Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease. in British journal of cancer / Br J Cancer. 2005 Sep 19;93(6):633-8. doi: 10.1038/sj.bjc.6602767.

2005
AOU San Luigi di Orbassano

Berruti A; Tucci M; Mosca A; Tarabuzzi R; Gorzegno G; Terrone C; Vana F; Lamanna G; Tampellini M; Porpiglia F; Angeli A; Scarpa RM; Dogliotti L;

Feasibility of 21-day continuous infusion of epirubicin in hormone-refractory prostate cancer patients. in Anticancer research / Anticancer Res. 2005 Nov-Dec;25(6C):4475-9.

2005
AOU San Luigi di Orbassano

Berruti A; Mosca A; Bitossi R; Gorzegno G; Guercio S; Poggio M; Tampellini M; Porpiglia F; Ostellino O; Scarpa RM; Dogliotti L;

Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up. in Urologic oncology / Urol Oncol. 2005 Jan-Feb;23(1):1-7. doi: 10.1016/j.urolonc.2004.06.003.

2005
AOU San Luigi di Orbassano

Berruti A; Fara E; Tucci M; Tarabuzzi R; Mosca A; Terrone C; Gorzegno G; Fasolis G; Tampellini M; Porpiglia F; De Stefanis M; Fontana D; Bertetto O; Dogliotti L;

Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines. in British journal of cancer / Br J Cancer. 2005 Feb 28;92(4):634-8. doi: 10.1038/sj.bjc.6602335.

2005
AOU San Luigi di Orbassano

Berruti A; Bitossi R; Gorzegno G; Bottini A; Generali D; Milani M; Katsaros D; Rigault de la Longrais IA; Bellino R; Donadio M; Ardine M; Bertetto O; Danese S; Sarobba MG; Farris A; Lorusso V; Dogliotti L;

Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial design. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2002 Oct 15;20(20):4150-9. doi: 10.1200/JCO.2002.08.012.

2002
AOU San Luigi di Orbassano

Berruti A; Bitossi R; Gorzegno G; Bottini A; Alquati P; De Matteis A; Nuzzo F; Giardina G; Danese S; De Lena M; Lorusso V; Farris A; Sarobba MG; DeFabiani E; Bonazzi G; Castiglione F; Bumma C; Moro G; Bruzzi P; Dogliotti L;

Background to and management of treatment-related bone loss in prostate cancer. in Drugs & aging / Drugs Aging. 2002;19(12):899-910. doi: 10.2165/00002512-200219120-00002.

2002
AOU San Luigi di Orbassano

Berruti A; Tucci M; Terrone C; Gorzegno G; Scarpa RM; Angeli A; Dogliotti L;

Independent factors predict supranormal CA 15-3 serum levels in advanced breast cancer patients at first disease relapse. in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine / Tumour Biol. 2001 Nov-Dec;22(6):367-73. doi: 10.1159/000050639.

2001
AOU San Luigi di Orbassano

Tampellini M; Berruti A; Gorzegno G; Bitossi R; Bottini A; Durando A; De Matteis A; Farris A; Donadio M; De Fabiani E; Manzin E; Arese P; Sarobba MG; Castiglione F; Moro G; Bonazzi G; Nuzzo F; Massobrio M; Dogliotti L;

Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin-A, prostate-specific antigen, and insulin-like growth factor-1 in advanced prostate cancer patients. in The Prostate / Prostate. 2001 May 15;47(3):205-11. doi: 10.1002/pros.1064.

2001
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Mosca A; Tarabuzzi R; Torta M; Mari M; Gorzegno G; Fontana D; Angeli A;

Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline. in The Journal of urology / J Urol. 2000 Oct;164(4):1248-53.

2000
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Bitossi R; Fasolis G; Gorzegno G; Bellina M; Torta M; Porpiglia F; Fontana D; Angeli A;

Evaluation by dual energy X-ray absorptiometry of changed bone density in metastatic bone sites as a consequence of systemic treatment. in Oncology reports / Oncol Rep. 2000 Jul-Aug;7(4):777-81. doi: 10.3892/or.7.4.777.

2000
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Osella G; Cerutti S; Reimondo G; Martino A; Gorzegno G; Catolla R; Angeli A;

Differential patterns of bone turnover in relation to bone pain and disease extent in bone in cancer patients with skeletal metastases. in Clinical chemistry / Clin Chem. 1999 Aug;45(8 Pt 1):1240-7.

1999
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Gorzegno G; Torta M; Tampellini M; Tucci M; Cerutti S; Frezet MM; Stivanello M; Sacchetto G; Angeli A;

Acute myeloblastic leukemia associated with mediastinal nonseminomatous germ cell tumors. Report on two cases. in Tumori / Tumori. 1995 Jul-Aug;81(4):299-301. doi: 10.1177/030089169508100417.

1995
AOU San Luigi di Orbassano

Berruti A; Pazè E; Fara E; Gorzegno G; Dogliotti L;

Hypertriglyceridemia during long-term interferon-alpha therapy: efficacy of diet and gemfibrosil treatment. A case report. in Tumori / Tumori. 1992 Oct 31;78(5):353-5. doi: 10.1177/030089169207800515.

1992
AOU San Luigi di Orbassano

Berruti A; Gorzegno G; Vitetta G; Tampellini M; Dogliotti L;